Difference between revisions of "Team:Toulouse/Parts"
| Line 161: | Line 161: | ||
</div> | </div> | ||
| − | <img src="https://static.igem.org/mediawiki/2015/e/eb/TLSE_Parts_image1.PNG" style="width: | + | <img src="https://static.igem.org/mediawiki/2015/e/eb/TLSE_Parts_image1.PNG" style="width:45%;"/> |
<div class="group center"> | <div class="group center"> | ||
Revision as of 14:36, 16 September 2015
NE PAS MODIFIER PROUT
In the list below you will find an overview over the BioBrick parts we added to the registry, which were created by the iGEM Toulouse 2015 team.
For our project, we worked on three different modules : attract the varroa, kill the mite and finally the circadian switch to alternatively produce the two molecules of interest, butyrate during the day and formate during the night.
| Name | Type | Genic construction | Lenghth (bp) | References |
|---|---|---|---|---|
| BBa_K1587000 | Composite (with RBS) | RBS-ho1 | 744 | [13] |
| BBa_K1587001 | Basic part | tesB | 861 | [3][4][5] |
| BBa_K1587002 | Composite (with RBS) | RBS-pcyA | 796 | [13] |
| BBa_K1587003 | Basic part | crt | 786 | [1] [2] [3] [4] [7] |
| BBa_K1587004 | Basic part (others) | pBla-RBS-ccr-RBS-hbd-RBS-crt-RBS- tesB-RBS-atoB-Terminator | 5175 | [1] [2] [3] [4] [6] |
| BBa_K1587005 | Basic part (others) | pBla-RBS-hbd-RBS-crt-RBS- tesB-RBS-atoB-Terminator | 3827 | [1] [2] [3] [4] [6] |
| BBa_K1587006 | Basic part (others) | pOmpC-LacIbox-RBS-cI | 905 | [12][13] |
| BBa_K1587007 | Basic part (others) | RBS-pflB-RBS-pflA-Terminator | 3093 | [7] [8] [9] [10] [11] |
Attraction (butyrate pathway)
The chassis we used is Escherichia coli, and this bacterium is not able to naturally produce butyrate. That is why we introduced genes from others bacterial strains to synthesize this molecule.
Basic parts
tesB (BBa_K1587001)
Gene from Escherichia coli involved in the butyrate pathway that enables its production directly from acyl-coAs. This group of enzymes catalyzes the hydrolysis of acyl-CoAs into free fatty acid (in our case, butyryl-coA into butyrate) plus reduced coenzyme A (CoA-SH).
